VeriHealthTM, a configurable end-to-end chip design platform for healthcare applications, has been launched by VeriSilicon (688521.SH), a leading SiPaaS (Silicon Platform as a Service) business. VeriHealth provides a complete solution for wearable health monitoring, including all processes from chip design to platform-level reference application development, and is based on VeriSilicon’s […]
Trending News
Wynn Las Vegas Launches Partnership with TB12, Offering Onsite Body Coach Sessions
Tom Brady and Alex Guerrero’s TB12, a holistic health and wellness business designed and inspired by the training programme of the renowned quarterback and his longtime Body Coach, have announced a partnership with Wynn Las Vegas. The TB12 Method, which consists of five pillars of flexibility, nutrition, hydration, movement, and […]
Delfi Diagnostics Selected as the Liquid Biopsy Partner for 4-IN-THE-LUNG-RUN: A Large-Scale European Lung Cancer Screening Study
The European Union is anticipated to launch a European lung cancer screening programme for people at risk due to their smoking and age based on the findings of the NELSON experiment. Delfi Diagnostics has been chosen as the liquid lung cancer biopsy partner in Europe’s multi-national, randomised, prospective lung cancer […]
Dr. Reddy’s Laboratories Announces the Launch of Lenalidomide Capsules in the U.S. With Two of Six Strengths Eligible for First-to-market, 180-day Exclusivity
Lenalidomide Capsules, a therapeutically similar and FDA-approved generic version of REVLIMID (lenalidomide) Capsules, were made available on the U.S. market today, according to Dr. Reddy’s Laboratories Ltd. (USFDA). Dr. Reddy’s is qualified for first-to-market, 180-day generic medication exclusivity for Lenalidomide Capsules in 2.5 mg and 20 mg strengths with this […]
BetterHelp Partners with Venus Williams, Frances Tiafoe and Taylor Fritz to Provide up to $3 Million in Free Therapy and Promote Mental Health Awareness
BetterHelp, the world’s largest therapy platform, today announced a promotional partnership with tennis superstars Venus Williams, Frances Tiafoe and Taylor Fritz to provide up to $3 million worth of free mental health therapy to people in need. The initiative is designed to shine a light on the importance of mental […]
CVS Health to Acquire Signify Health
A definitive agreement between CVS Health and Signify Health states that CVS Health will buy Signify Health for $30.50 per share in cash, for a total transaction value of almost $8 billion. In terms of value-based care, provider enablement, and health risk assessments, Signify Health is a pioneer. Signify Health […]
Innate Pharma to Present Lacutamab PTCL Phase 1b Design and ANKET™ Platform at ESMO 2022
The following presentations will be made during the ESMO (European Society for Medical Oncology) Annual Meeting 2022, which will take place from September 9–13, 2022, in Paris, France, according to an announcement made today by Innate Pharma SA. 1. In a multi-center Phase Ib trial, lacutamab safety and efficacy in […]
Novavax Nuvaxovid™ COVID-19 Vaccine Recommended by CHMP for Expanded Conditional Marketing Authorization in the European Union as a Booster for Adults Aged 18 and Older
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine has been recommended for expanded conditional marketing authorization (CMA) in the European Union (EU) as a homologous and heterologous booster for active immunization to prevent coronavirus disease […]
HearingLife Now Offers Oticon Own™, the World’s Smallest Hearing Aid with BrainHearing™ Technology
Life-changing technology in an in-the-ear hearing aid The new Oticon Own is a fully customized in-the-ear hearing aid that works more like your brain because it is learned through experience.* Built using BrainHearing™ technology and designed for discreetness, Oticon Own offers a truly personalized listening experience. Oticon Own is a […]
Revision Skincare® Announces Strategic Partnership with RVL Pharmaceuticals, Inc.
A partnership between Revision Skincare and RVL Pharmaceuticals, Inc., maker of UPNEEQ, the first and only prescription eye drop for people with acquired ptosis (low-lying lids), was announced today. RVL Pharmaceuticals, Inc. This strategic agreement brings together two innovative disruptors in the skincare and aesthetics sectors who are both committed […]
